BackSolid Biosciences Overview
Solid Biosciences Inc

Solid Biosciences Target Price

See Solid Biosciences's analyst price targets ($17) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$9.08

Average Target Price

$17.0087.2% upside

2 analysts in the last 4 months

High: $18 | Low: $16

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-13Piper SandlerBiren Amin$1898.2% upsideOpen
2026-05-13Wedbush$1676.2% upsideOpen
2025-12-04NeedhamGil Blum$1676.2% upsideOpen
2025-11-04Barclays$90.9% downsideOpen
2025-07-21Cantor FitzgeraldCharles Duncan$1676.2% upsideOpen
2024-06-24Leerink PartnersJoseph Schwartz$1232.2% upsideOpen
2024-05-31Piper SandlerBiren Amin$20120.3% upsideOpen
2024-05-16BarclaysGena Wang$1898.2% upsideOpen
2024-03-13Raymond JamesChristopher Raymond$20120.3% upsideOpen

Solid Biosciences (SLDB) FAQ

The latest target price for SLDB is $17. Investors often review this figure alongside Solid Biosciences's historical trend and sector peers before judging valuation or financial health.

Solid Biosciences trades near $9.08 while the consensus target sits at $17 (87.2% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting SLDB's target price ($17), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Solid Biosciences's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.